Literature DB >> 24199788

Clozapine-induced elevated C-reactive protein and fever mimic infection.

Matej Štuhec1.   

Abstract

Clozapine-induced fever has been reported frequently, but clozapine-induced elevated serum C-reactive protein (S-CRP) over 100 mg/L with early onset, without associated myocarditis, has not been reported in the literature. In this case report, we present a case of an 80-year-old Slovenian female with dementia and psychotic symptoms who developed elevated S-CRP (122 mg/L) and fever (38.2 °C) on the seventh day with 25 mg of clozapine daily, which improved after clozapine discontinuation. The patient did not have symptoms and signs of infection. This case report can be used to remind clinicians of keeping in mind the potential of clozapine associated with very high elevated S-CRP with fever, which can be easily confused with more serious conditions.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Case report; Clozapine; Elevated C-reactive protein; Mimic infection

Mesh:

Substances:

Year:  2013        PMID: 24199788     DOI: 10.1016/j.genhosppsych.2013.03.022

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  4 in total

Review 1.  Auditory hallucinations associated with nitrofurantoin use: case report and review of the literature.

Authors:  Matej Štuhec
Journal:  Wien Klin Wochenschr       Date:  2014-08-15       Impact factor: 1.704

2.  Inflammatory response to clozapine in the absence of myocarditis: case report.

Authors:  Patrick Davey; Siobhan Gee; Sukhi S Shergill
Journal:  BJPsych Open       Date:  2016-06-22

Review 3.  Venous Thromboembolism During Treatment with Antipsychotics: A Review of Current Evidence.

Authors:  Anna K Jönsson; Johan Schill; Hans Olsson; Olav Spigset; Staffan Hägg
Journal:  CNS Drugs       Date:  2018-01       Impact factor: 5.749

4.  Caffeine-clozapine interaction associated with severe toxicity and multiorgan system failure: a case report.

Authors:  Alex Yartsev; Carmelle Peisah
Journal:  BMC Psychiatry       Date:  2021-04-13       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.